v3.26.1
Note 15 - Dermadoctor Divestiture (Tables)
12 Months Ended
Dec. 31, 2025
DERMAdoctor [Member]  
Notes Tables  
Disposal Groups, Including Discontinued Operations [Table Text Block]
   

For the years ended

December 31,

 
   

2025

   

2024

(As Revised)

 
                 

Net sales

  $     $ 717  

Cost of goods sold

          493  

Gross profit

          224  

Operating expenses:

               

Research and development

          2  

Sales and marketing

          292  

General and administrative

          48  

Total operating expenses

          342  

Operating loss

          (118 )
                 

Loss on divestiture

          (871 )
                 

Net loss from discontinued operations

  $     $ (989 )
   

For the years ended

December 31,

 
   

2025

   

2024

(As Revised)

 
                 

Operating activities:

               

Net loss from discontinued operations

  $     $ (989 )

Adjustments to reconcile net loss to net cash used in operating activities:

               

Non-cash loss on divestiture

          865  

Changes in operating assets and liabilities:

               

Accounts receivable

          (262 )

Inventory

          183  

Prepaid expenses and other current assets

          (4 )

Other assets

            15  

Accounts payable and accrued liabilities

          63  

Operating lease liabilities

          (31 )

Net cash used in operating activities, discontinued operations

          (160 )
                 

Investing activities:

               

Proceeds from divestiture

          1,070  

Cash transferred to New Age Investments, LLC

          (46 )

Net cash provided by investing activities, discontinued operations

          1,024  
                 

Net increase in cash and cash equivalents, discontinued operations

  $     $ 864